Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Corporate Headquarters: , 235 E. 42nd Street, New York, NY, 10017, US
Pfizer CentreOne is a global contract development and manufacturing organization (CDMO) within Pfizer and a leading supplier of specialty APIs. Our global manufacturing network includes more than 35 sites across six continents. Backed by Pfizer resources, we deliver technical expertise, global regulatory support and long-term supply. We are ready to be your strategic partner to help you change patients’ lives – because Time is Life. To learn more about what makes us an altogether different CDMO, visit www.pfizercentreone.com.
Insight on market dynamics driving OSD forms, key development and manufacturing challenges, and the specialized capabilities needed to address them.
Released By Pfizer CentreOne
Vice President and General Manager of Pfizer CentreOne talks with Ben Locwin about drug development trends and challenges and Pfizer’s lightspeed approach.
Global Head of Strategic Account Management for Pfizer CentreOne talks with host Ben Locwin about the advantages of working with an integrated CDMO.
Sterile injectables play a pivotal role in delivering crucial medications, including antibiotics, vaccines, and biologics, directly into the bloodstream.
An influx of innovative molecules pose formulation development challenges due to absorption and bioavailability issues.
This whitepaper looks at the broad set of trends influencing pharmaceutical development and manufacturing strategy today.
Revenue in the quarter was impacted by declines in COVID-19 product sales.
By: Kristin Brooks
Acquisition would provide Pfizer entry into the lucrative weight-loss drug market.
As Wheeler's exclusive commercialization partner in the region, Mitsubishi will support the recruitment of new client relationships.
By: Charlie Sternberg
Wan will help accelerate Medison’s growth in the region.
By: Rachel Klemovitch
Agrees to most-favored-nation pricing and plans further investment in U.S. R&D.
AstraZeneca to invest $50 billion in manufacturing and R&D to support domestic sourcing.
Data management, study design, and the groundwork needed to build pharma’s digital revolution.
By: Nicolas Descamps
The agreement includes a 3-year tariff exemption for Pfizer products, contingent on increased U.S. manufacturing investment.
The proposed acquisition will add four highly differentiated clinical-stage incretin and amylin programs to Pfizer’s pipeline.
Goodwin proven expertise in global clinical development and further strengthens company focus on operational excellence, quality and delivery.
The approval covers the LP.8.1-adapted vaccine, designed to address evolving SARS-CoV-2 sublineages.
Makes targeted investments and builds new partnerships in the APAC region.
CureVac and GSK will receive $740 million and single-digit royalties on COVID-19 vaccine sales in the U.S. going forward.
These three executives will support Hansa’s growth and further enhance the company’s expertise across legal, human resources, and corporate affairs.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
